J.Jpn. Surg. Soc.. 91(9): 1368-1370, 1990
Report on the annual meeting
POSTOPERATIVE LONG-TERM CANCER CHEMOTHERAPY（PLCC）IS EFFECTIVE FOR PATIENTS WITH GASTRIC CANCER FOLLOWING CURATIVE RESECTION
|
Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan Yoshihiko Maehara, Yasunori Emi, Yoshihisa Sakaguchi, Sunao Moriguchi, Shunichi Tsujitani, Shunji Kohnoe, Keizo Sugimachi |
The study consisted of 255 patients during 1965 to 1983 ; 118 patients wihout chemotheapy and 137 patients receiving PLCC. In all cases, 15-year survival rate of PLCC group (56.9%) was significantly higher than that of no chemotherapy group (45.7%) (p<0.05). In cases of n(-) or ps(-), the PLCC prolonged the 15-year survival rates (p<0. 05), while in cases of n(+) and/or ps(+), differences were not noted between the groups.
Our findings show that PLCC improves 15-year survival for patients with advanced gastric cancer following curative resection. Aggressive chemotherapy should be done for patients of n(+) and/or ps(+).
To read the PDF file you will need Adobe Reader installed on your computer.